CONATUS PHARMACEUTICALS INC's ticker is CNAT and the CUSIP is 20600T108. A total of 60 filers reported holding CONATUS PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 0.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $3,000 | 0.0% | 1,462 | +162.5% | 0.00% | – |
| Q3 2018 | $3,000 | -88.0% | 557 | -90.7% | 0.00% | -100.0% |
| Q2 2018 | $25,000 | +1150.0% | 5,988 | +1404.5% | 0.00% | – |
| Q1 2018 | $2,000 | -50.0% | 398 | -58.8% | 0.00% | -100.0% |
| Q4 2017 | $4,000 | -89.2% | 967 | -85.4% | 0.00% | -66.7% |
| Q3 2017 | $37,000 | +3600.0% | 6,641 | +4931.1% | 0.00% | – |
| Q1 2017 | $1,000 | – | 132 | +57.1% | 0.00% | – |
| Q1 2016 | $0 | -100.0% | 84 | -98.5% | 0.00% | -100.0% |
| Q4 2015 | $16,000 | +60.0% | 5,557 | +147.9% | 0.00% | +200.0% |
| Q3 2015 | $10,000 | +900.0% | 2,242 | +1560.7% | 0.00% | – |
| Q2 2015 | $1,000 | -85.7% | 135 | -84.9% | 0.00% | -100.0% |
| Q1 2015 | $7,000 | +75.0% | 893 | +64.2% | 0.00% | – |
| Q4 2014 | $4,000 | -81.0% | 544 | -84.0% | 0.00% | -100.0% |
| Q3 2014 | $21,000 | -50.0% | 3,390 | -33.5% | 0.00% | -60.0% |
| Q1 2014 | $42,000 | – | 5,099 | +20296.0% | 0.01% | – |
| Q3 2013 | $0 | – | 25 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JBF Capital, Inc. | 520,553 | $161,000 | 0.03% |
| Kalos Management, Inc. | 43,940 | $13,000 | 0.01% |
| ACADIAN ASSET MANAGEMENT LLC | 1,351,000 | $419,000 | 0.00% |
| Quilter Plc | 60,546 | $19,000 | 0.00% |
| ALBION FINANCIAL GROUP /UT | 12,000 | $4,000 | 0.00% |
| REILLY FINANCIAL ADVISORS, LLC | 22,011 | $7,000 | 0.00% |
| MORGAN STANLEY | 1,900 | $1,000 | 0.00% |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM | 24,900 | $8,000 | 0.00% |
| BlackRock Inc. | 645,611 | $200,000 | 0.00% |
| Bank of New York Mellon Corp | 137,500 | $43,000 | 0.00% |